Veterinary Infectious Disease Diagnostics Market Report 2026

Veterinary Infectious Disease Diagnostics Market Overview

• Veterinary Infectious Disease Diagnostics market size has reached to $2.11 billion in 2025 • Expected to grow to $3.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Increased Adoption Of Companion Animals • Market Trend: Innovative Solutions Enhancing Rapid Disease Detection And Veterinary Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Infectious Disease Diagnostics Market?

The veterinary infectious disease diagnostics refer to diagnostic services that are used for the identification of infectious diseases in animals. These are the sets of infectious diseases and the factors that impact the health of livestock, domestic animals, and wildlife. Veterinary diagnostics has become essential to ensure the overall well-being of animals. These diagnose the infections caused in all types of animals. The main types of veterinary infectious disease diagnostics are viral infections, bacterial infections, parasitic infections, and other infections. Bacterial infections are transmitted from dogs to humans by dog bites. However, other infections caused by protozoa have fecal-oral transmission. The different animals include companion animals, food-producing animals, and involve various technologies such as immunodiagnostics, molecular diagnostics, and other technologies. These are used in reference laboratories, veterinary hospitals and clinics, point of care, research institutes and universities, and other end users.

What Is The Veterinary Infectious Disease Diagnostics Market Growth Forecast?

The veterinary infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to advancements in molecular and immunodiagnostic technologies, increasing adoption of point-of-care testing devices, rising investments in veterinary diagnostic infrastructure, growing demand for rapid infectious disease detection, expansion of research institutes and universities in veterinary health. Major trends in the forecast period include increasing adoption of molecular diagnostics, rising demand for point-of-care testing, growing focus on companion animal health, expansion of reference laboratories, technological advancements in immunodiagnostics.

What Is The Driver Of The Veterinary Infectious Disease Diagnostics Market?

Rising pet adoption is expected to propel the growth of the veterinary infectious disease diagnostics market going forward. Pet adoption is the process of taking responsibility for a homeless or abandoned animal by providing it with a permanent home and care. Pet adoption is rising because more people are seeking companionship, leading them to provide homes for homeless animals and improve their well-being. Veterinary Infectious Disease Diagnostics helps pet adoption by ensuring animals are healthy and free from contagious diseases, giving adopters confidence to bring pets home safely. For instance, in 2023, according to the Shelter Animals Count, a US-based non-governmental organization, in 2023 dog adoptions increased by 109,000 compared to 2022, indicating positive growth in adoption rates. However, the total number of dogs adopted in 2023 remains nearly 108,000 lower than in the prior year. Therefore, the rising pet adoption rate is driving the veterinary infectious disease diagnostics industry during forecast period.

Key Players In The Global Veterinary Infectious Disease Diagnostics Market

Major companies operating in the veterinary infectious disease diagnostics market are Zoetis Inc., IDEXX Laboratories Inc., IDvet, NEOGEN Corporation, INDICAL BIOSCIENCE GmbH, Heska Corporation, Bio‑X Diagnostics, Virbac, Covetrus Inc., VCA Inc., Vetoquinol SA, BioChek B V, BioNote Inc, MEGACOR Diagnostik GmbH, AniCon Labor GmbH, AusDiagnostics Pty Ltd, Demedetic Diagnostics GmbH, Innovative Diagnostics, GD Animal Health, Biovet Inc, GeneReach, Biogal, Fassisi GmbH, Midland BioProducts, Vetsina Animal Diagnostics, Eurofins Technologies

Global Veterinary Infectious Disease Diagnostics Market Trends and Insights

Major companies operating in the veterinary diagnostics market are focusing on developing advanced solutions, such as rapid molecular diagnostic kits, to replace traditional time-consuming laboratory tests. A rapid molecular diagnostic kit refers to a tool that enables fast, accurate detection of infectious agents in animals, helping veterinarians make timely decisions while minimizing laboratory workload. For instance, in June 2025, bioMérieux SA, a France-based diagnostics company, launched VETFIRE, a PCR kit for equine infectious respiratory disease testing. This innovation replaces conventional laboratory testing by providing rapid, sensitive, and multiplex detection of seven equine respiratory pathogens directly in veterinary practices. It delivers fast results while allowing veterinarians to accurately diagnose infections, monitor disease outbreaks, and implement treatment plans without delay. Integrated with bioMérieux’s diagnostic solutions, such as antimicrobial resistance monitoring and laboratory support services, it offers a seamless diagnostic experience. The rapid molecular kit improves diagnostic accuracy, simplifies veterinary operations, and helps enhance animal health outcomes.

What Are Latest Mergers And Acquisitions In The Veterinary Infectious Disease Diagnostics Market?

In April 2023, Mars Inc., a US-based provider of pet care products and veterinary diagnostic solutions, acquired Heska Corporation for an undisclosed amount. With this acquisition, Mars aimed to broaden its veterinary infectious disease diagnostics and point of care testing capabilities, expanding its comprehensive diagnostic offerings and accelerating research, development, and global market reach. Heska Corporation is a US based provider of advanced veterinary diagnostic instruments, consumables, point of care infectious disease tests, informatics platforms, and specialty animal healthcare products.

What Defines the Veterinary Infectious Disease Diagnostics Market?

The veterinary infectious disease diagnostics market includes revenues earned by entities by identifying and determining whether an animal has any viral, bacterial, parasitic, or other types of illnesses. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Infectious Disease Diagnostics Market Report 2026?

The veterinary infectious disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary infectious disease diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.